K102964

Substantially Equivalent

EU-TTG IGA AND EU-TTG IGG

Applicant: Grifols USA, Inc.
Product code: MVM
Advisory panel: Immunology
Date received: 2010-10-05
Decision date: 2011-03-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.